Back to search results

Resilience Program for Lymphoma Survivors

This study is looking at whether a program called SMART3RP-Lymphoma can help lymphoma survivors cope better with the challenges after treatment. SMART3RP-Lymphoma is a mind-body group program that combines relaxation techniques, stress management, and positive psychology. You would either receive this program or "Enhanced Usual Care," which involves a meeting with a social worker and a list of resources. The study wants to see if SMART3RP-Lymphoma improves coping skills compared to Enhanced Usual Care. To join, you need to be at least 18 years old, speak English, and have finished active lymphoma treatment within the last two years. The study plans to enroll 254 people, but its current status is unclear.

Study design
This is a randomized controlled trial comparing SMART3RP-Lymphoma to Enhanced Usual Care, with 254 participants planned.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your coping scores will be measured from the beginning of the study up to 3 months later.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07014293

Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors

Recruiting
NAAges 18+InterventionalSupportive care
Massachusetts General Hospital
~254 participants
Updated 2026-08-11 on ClinicalTrials.gov
What's tested:Enhanced Usual CareSMART3RP-Lymphoma

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change from Baseline in Coping Scores on the Measure of Current Status Scale (MOCS-A)
Measured over Baseline to 3 month follow up

Conditions

Lymphoma

Explore related trials

Lymphoma

NCT07014293

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Mass General Brigham

    Boston, Massachusettsstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Giselle Perez, PhD
[email protected]
617-724-0765
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

English speaking adult (18 years or older at enrollment)
At least 6-months post-lymphoma diagnosis and within 2 years of completing active, curative treatment for lymphoma (includes surgery, chemotherapy/immunotherapy/radiation therapy, or other)

Exclusion

Active Psychiatric or cognitive comorbidity as determined by site PI or treating clinician
Unwilling or unable to participate using telehealth platform

What this trial measures

  • Change from Baseline in Coping Scores on the Measure of Current Status Scale (MOCS-A)Baseline to 3 month follow up

    The Measure of Current Status Scale (MOCS-A) measures coping processes on 4 domains: ability to relax, recognize stress, elicit support, and restructure thoughts. It is a 13-item scale where each item is measured on a 0-4 scale.